The mammalian target of rapamycin (mTOR) is a central cell growth regulator that integrates a wide range of growth stimulating and inhibitory signals. mTOR inhibitors are FDA approved drugs for immunosuppression in organ transplantation and cancer treatment. The mTOR kinase forms two complexes, TORC1 and TORC2, with distinct subunit composition and physiological functions. In response to growth factors and nutrients, TORC1 promotes cell growth by stimulating translation. Overwhelming evidence has also demonstrated a key role of TORC1 in inhibiting autophagy. However, the molecular mechanism of TORC1 in autophagy regulation is unknown. The AMP activated protein kinase (AMPK) is a key cellular energy sensor and functions to maintain cellular energy homeostasis. AMPK has been implicated in autophagy induction, yet little is known about the mechanism of AMPK in regulating the autophagy machinery. Our preliminary studies indicate that TORC1 and AMPK can regulate key components of the autophagy machinery by direct phosphorylation. The long-term goal of this project is to elucidate the molecular mechanisms of TORC1 and AMPK in induction of autophagy in response to nutrient signals.
The specific aims for this proposal are: 1 To elucidate the functional significance of ULK1 phosphorylation by TORC1 in autophagy 2 To determine the mechanism of AMPK in regulating ULK1 activation and function in autophagy 3 To investigate the mechanism of AMPK in VPS34 regulation during autophagy
Autophagy is a regulated catabolic process in which the cell degrades its own components through fusion with lysosomes;it is an adaptive starvation response to generate nutrients for maintaining essential cellular functions. Autophagy also plays important roles in removing toxic protein aggregates, damaged organelles, and infected pathogens;dysregulation of autophagy has been implicated in many diseases, including cancer and neurodegeneration. The goal of this proposal is to gain knowledge of autophagy regulation, particularly to understand the mechanisms of mTOR and AMPK, both are key nutrient signaling molecules, in autophagy regulation;the completion of this project will not only advance our understanding the fundamental biology of autophagy but also provide important information for therapeutic interventions of human diseases such as cancer and neurodegenerative disorders.
|Fu, Vivian; Moroishi, Toshiro; Guan, Kun-Liang (2016) Glycoholics Anonymous: Cancer Sobers Up with mTORC1. Cancer Cell 29:432-4|
|Lin, Huai-Peng; Cheng, Zhou-Li; He, Ruo-Yu et al. (2016) Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth. Cancer Res 76:6924-6936|
|Plouffe, Steven W; Meng, Zhipeng; Lin, Kimberly C et al. (2016) Characterization of Hippo Pathway Components by Gene Inactivation. Mol Cell 64:993-1008|
|Meng, Zhipeng; Moroishi, Toshiro; Guan, Kun-Liang (2016) Mechanisms of Hippo pathway regulation. Genes Dev 30:1-17|
|Gong, Rui; Hong, Audrey W; Plouffe, Steven W et al. (2015) Opposing roles of conventional and novel PKC isoforms in Hippo-YAP pathway regulation. Cell Res 25:985-8|
|Yu, Fa-Xing; Zhao, Bin; Guan, Kun-Liang (2015) Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 163:811-28|
|Kim, Young Chul; Guan, Kun-Liang (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125:25-32|
|Yuan, Hai-Xin; Wang, Zhen; Yu, Fa-Xing et al. (2015) NLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibition. Genes Dev 29:2362-76|
|Yuan, Hai-Xin; Guan, Kun-Liang (2015) The SIN1-PH Domain Connects mTORC2 to PI3K. Cancer Discov 5:1127-9|
|Liu, G; Yu, F-X; Kim, Y C et al. (2015) Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Oncogene 34:3536-46|
Showing the most recent 10 out of 59 publications